PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 39 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | 0.0% | 9,250 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | – | 9,250 | -24.2% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 12,205 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 12,205 | +313.0% | 0.00% | – |
| Q4 2016 | $0 | – | 2,955 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 2,955 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 2,955 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $1,000 | 0.0% | 2,955 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,000 | -50.0% | 2,955 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,000 | 0.0% | 2,955 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,000 | 0.0% | 2,955 | +34.0% | 0.00% | 0.0% |
| Q1 2015 | $2,000 | +100.0% | 2,205 | +29.3% | 0.00% | 0.0% |
| Q4 2014 | $1,000 | – | 1,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Schonfeld Group Holdings LLC | 15,000 | $12,000 | 0.09% |
| Cutter & CO Brokerage, Inc. | 94,500 | $77,000 | 0.03% |
| PRINCETON CAPITAL MANAGEMENT LLC | 25,000 | $20,000 | 0.02% |
| STANCORP INVESTMENT ADVISERS INC | 14,000 | $11,000 | 0.01% |
| WADE G W & INC | 30,000 | $24,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 18,000 | $15,000 | 0.00% |
| Estate Counselors, LLC | 10,000 | $8,000 | 0.00% |
| LUPO SECURITIES, LLC | 800 | $1,000 | 0.00% |
| Virtu KCG Holdings LLC | 122,755 | $100,000 | 0.00% |
| Commonwealth Equity Services, Inc | 80,500 | $66,000 | 0.00% |